Azoramide ameliorated tachypacing-induced injury of atrial myocytes differentiated from human induced pluripotent stem cell by regulating endoplasmic reticulum stress

Azoramide ameliorated tachypacing-induced injury of atrial myocytes differentiated from human induced pluripotent stem cell by regulating endoplasmic reticulum stress

Hypoglycemic agents have been shown to reduce the incidence of atrial fibrillation (AF) in patients with diabetes mellitus. Azoramide is a novel anti-diabetic agent which protects cells against endoplasmic reticulum (ER) stress; however, the cardioprotective effect of azoramide against AF is not cle...

Full description

Bibliographic Details
Main Authors: Weilun Miao, Jiaojiao Shi, Jiayi Huang, Yongpin Lin, Chang Cui, Yue Zhu, Bingyu Zheng, Mingfang Li, Qi Jiang, Minglong Chen
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:Stem Cell Research
Subjects:
Atrial fibrillation1
Human induced pluripotent stem cell2
Electrical tachypacing3
Azoramide5
ER stress
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506122000356

Internet

http://www.sciencedirect.com/science/article/pii/S1873506122000356

Similar Items